ALTERATIONS IN PULMONARY PROTECTIVE ENZYMES FOLLOWING SYSTEMIC BLEOMYCIN TREATMENT IN MICE

被引：41

作者：

FILDERMAN, AE ^{[1
]}

GENOVESE, LA ^{[1
]}

LAZO, JS ^{[1
]}

机构：

[1] YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510

来源：

关键词：

D O I：

10.1016/0006-2952(88)90518-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1111 / 1116

页数：6

共 31 条

[1]

ARRICK BA, 1984, CANCER RES, V44, P4224

[2]

BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO

[3]

2-N

[4]

BOWDEN DH, 1984, LAB INVEST, V50, P487

[5]

BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[6] THE COORDINATION CHEMISTRY OF BLEOMYCIN - A REVIEW [J].

DABROWIAK, JC .

[7]

DOUGLAS KT, 1983, BIOMED PHARMACOTHER, V37, P191

[8]

FEINSTEIN RN, 1949, J BIOL CHEM, V180, P1197

[9]

FILDERMAN A E, 1985, American Review of Respiratory Disease, V131, pA381

[10] INHIBITION OF DNA POLYMERASE-ALPHA BY BLEOMYCIN [J].

FITZGERALD, G ;

WICK, MM .